Preoperative angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and acute kidney injury after high-risk cardiac surgery: a multicenter prospective cohort study
Brazilian Journal of Anesthesiology (English Edition) · 2026-07 · 76 (4) · 844786
DOI: 10.1016/j.bjane.2026.844786 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Brazilian Journal of Anesthesiology (English Edition), 2026-07. Verfasst von Iñigo Rubio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clínica Universidad de Navarra, Department of Anesthesiology & Critical Care Medicine, Pamplona, Spain. Hauptthemen laut MEDLINE: Acute Kidney Injury, Cardiac Surgical Procedures, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Navarra, Rosa, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medicine.
Abstract (Originalsprache)
Background
The impact of preoperative Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers (ACEI/ARB) on cardiac surgery-associated Acute Kidney Injury (AKI) remains elusive. We sought to evaluate the association of ACEI/ARB use with stage 2 or 3 AKI and in-hospital mortality, while evaluating whether preoperative withholding versus continuation strategies modulate clinical outcomes.
Methods
Multicenter prospective cohort study involving 14 Spanish and British hospitals. The study population comprised high-risk cardiac surgery patients (Cleveland Clinic Score ≥ 4).
Results
Among 249 patients (mean age: 69.5 years; 39% women; 53.8% ACEI/ARB users), the overall incidence of stage 2 or 3 AKI was 32.9%. ACEI/ARB use was associated with a significantly higher likelihood of stage 2 to 3 AKI (38.8% vs. 26.1%; adjusted OR = 2.79; 95% CI 1.47-5.30; p = 0.002). The adjusted risk difference was 0.188 (95% CI 0.079-0.298; p = 0.001), yielding a number needed to harm of 5.3. Sensitivity analyses confirmed the robustness of these findings, with an E-value of 2.73 (lower limit: 1.72) and consistent results using augmented inverse probability weighting (average treatment effect: 0.191; 95% CI 0.081-0.300; p = 0.001). No statistically significant associations were observed in in-hospital mortality or the impact of preoperative withholding versus continuation strategies on clinical outcomes.
Conclusion
This study suggests preoperative ACEI/ARB use may be associated with an increased incidence of stage 2 or 3 AKI. While differences in in-hospital mortality and preoperative withholding versus continuation strategies did not reach statistical significance, these findings reveal clinical trends that warrant further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clínica Universidad de Navarra, Department of Anesthesiology & Critical Care Medicine, Pamplona, Spain.
- Hospital Universitario Ramón y Cajal, Department of Anesthesiology & Perioperative Medicine, Madrid, Spain.
- Hospital Clínico Universitario de Valladolid, Department of Anesthesiology & Perioperative Medicine, Valladolid, Spain.
- St Bartholomew's Hospital, Barts Heart Centre, Department of Anaesthesia & Perioperative Medicine, London, United Kingdom.
- Clínica Universidad de Navarra, Central Clinical Trials Unit, Research Support Service, Pamplona, Spain; Public University of Navarra, Department of Health Sciences, Pamplona, Spain. Electronic address: jnunezco@unav.es.
- Clínica Universidad de Navarra, Department of Anesthesiology & Critical Care Medicine, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, IdiSNA, Pamplona, Spain.
Förderung
- Universidad de Navarra
- Rosa
- Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medicine
Zitieren
APA
Rubio, I., Candela, A., Echarri, G., Callejas, R., Tamayo, E., Nagore, D., Núñez-Córdoba, J. M., & Vives, M. (2026). Preoperative angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and acute kidney injury after high-risk cardiac surgery: a multicenter prospective cohort study. Brazilian Journal of Anesthesiology (English Edition), 76(4), 844786. https://doi.org/10.1016/j.bjane.2026.844786
Vancouver
Rubio I, Candela A, Echarri G, Callejas R, Tamayo E, Nagore D, et al. Preoperative angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and acute kidney injury after high-risk cardiac surgery: a multicenter prospective cohort study. Brazilian Journal of Anesthesiology (English Edition). 2026;76(4):844786. doi:10.1016/j.bjane.2026.844786
BibTeX
@article{Rubio2026,
author = {Rubio, Iñigo and Candela, Angel and Echarri, Gemma and Callejas, Raquel and Tamayo, Eduardo and Nagore, David and Núñez-Córdoba, Jorge M and Vives, Marc},
title = {Preoperative angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use and acute kidney injury after high-risk cardiac surgery: a multicenter prospective cohort study},
journal = {Brazilian Journal of Anesthesiology (English Edition)},
year = {2026},
volume = {76},
number = {4},
pages = {844786},
doi = {10.1016/j.bjane.2026.844786}
}
EUVIMED